Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?

@article{Riis1990IsIP,
  title={Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?},
  author={Bente Juel Riis and Claus Christiansen and Julia Sidenius Johansen and Jill Jacobson},
  journal={The Journal of clinical endocrinology and metabolism},
  year={1990},
  volume={70 4},
  pages={920-4}
}
Recent studies have shown that treatment with the LHRH agonist nafarelin gives symptomatic and objective relief to women with endometriosis. Such a treatment, however, results in increased bone turnover and loss of bone mass. In the present study 17 women with endometriosis were treated with 400 mg nafarelin combined with 1.2 mg norethisterone (NET) for 6 months, followed by 6 months with only 1.2 mg NET. The data were compared to data from a previously published study of 9 women treated for 6… CONTINUE READING
17 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

Similar Papers

Loading similar papers…